Progress on Biological Functions and Mechanisms of TET Enzymes

doi:10.19586/j.2095-2341.2022.0029

Current Biotechnology ›› 2022, Vol. 12 ›› Issue (5): 721-727.DOI: 10.19586/j.2095-2341.2022.0029

• Reviews • Previous Articles Next Articles

Progress on Biological Functions and Mechanisms of TET Enzymes

Yubing ZENG¹(), Xuejia HE¹^,², Fan LIU¹^,³, Pei PEI¹, Shan WANG¹()

^1.Beijing Municipal Key Laboratory of Child Development and Nutriomics，Capital Institute of Pediatrics，Beijing 100020，China
^2.Capital Institute of Pediatrics-Peking University Teaching Hospital，Beijing 100020，China
^3.Graduate School?of?Peking?Union?Medical?College，Capital?Institute?of?Pediatrics，Beijing 100020，China

Received:2022-03-10 Accepted:2022-05-23 Online:2022-09-25 Published:2022-09-30
Contact: Shan WANG

TET酶的生物学功能及相关机制的研究进展

曾雨冰¹(), 何学佳¹^,², 刘帆¹^,³, 裴培¹, 王珊¹()

^1.首都儿科研究所，儿童发育营养组学北京市重点实验室，北京 100020
^2.北京大学首都儿科研究所教学医院，北京 100020
^3.北京协和医学院研究生院，首都儿科研究所，北京 100020

通讯作者: 王珊
作者简介:曾雨冰 E-mail：xxz_007@163.com；
基金资助:
国家自然科学基金项目(82071690);首都儿科研究所所级基金项目(FX-2020-05)

Abstract

Abstract:

DNA methylation and demethylation are common epigenetic modification， which mediate a variety of physiological and pathological processes， and participate in the regulation of gene expression. Its dynamic equilibriums maintain biological genetic stability. DNA methyltransferase （DNMT） including DNMT1， DNMT3A， DNMT3B， DNMT3L and DNA demethylase mainly refer to the ten-eleven translocation （TET） family proteins， and TET1， TET2， TET3 are essential DNA methylases and DNA demethylases， which are the vital enzymes responsible for regulating DNA methylation and demethylation. TET enzymes are the most important enzyme found to promote the process of DNA demethylation. This paper summarized the mechanism of TET demethylases in DNA demethylation， and discussed its key role in growth， development and diseases， which amied to provide new ideas for subsequent epigenetic research.

Key words: epigenetics, TET enzymes, DNA demethylation

摘要：

DNA甲基化（DNA methylation）及去甲基化属于常见的表观遗传修饰，可介导多种生理和病理过程。DNA甲基化及去甲基化修饰参与基因的表达调控，且二者的动态平衡可以维持遗传表达稳定性。DNA甲基转移酶（DNA methyltransferase，DNMT）主要包括DNMT1、DNMT3A、DNMT3B、DNMT3L，DNA去甲基化酶（DNA demethylase）主要指10-11易位蛋白（ten-eleven-translocation protein，TET）家族，包括TET1、TET2、TET3，是调节DNA甲基化和去甲基化的重要酶类。TET酶是目前发现的调节DNA去甲基化（DNA demethylation）过程中最重要的酶。综述了TET酶在DNA去甲基化修饰中的作用机制，探讨了DNA去甲基化酶在生长发育和疾病中的关键作用，以期为今后表观遗传学的相关研究提供新思路。

关键词: 表观遗传学, TET酶, DNA去甲基化

CLC Number:

Q753

Yubing ZENG, Xuejia HE, Fan LIU, Pei PEI, Shan WANG. Progress on Biological Functions and Mechanisms of TET Enzymes[J]. Current Biotechnology, 2022, 12(5): 721-727.

曾雨冰, 何学佳, 刘帆, 裴培, 王珊. TET酶的生物学功能及相关机制的研究进展[J]. 生物技术进展, 2022, 12(5): 721-727.

Figures/Tables 3

References 59

1	CHEN Z, ZHANG Y. Role of mammalian DNA methyltransferases in development[J]. Annu. Rev. Biochem., 2020, 89: 135-158.
2	KUZNETSOV N A, KANAZHEVSKAYA L Y, FEDOROVA O S. DNA demethylation in the processes of repair and epigenetic regulation performed by 2-Ketoglutarate-dependent DNA dioxygenases[J/OL]. Int. J. Mol. Sci., 2021, 22(19): 10540 [2022-01-07]. .
3	SMALLWOOD S A, KELSEY G. De novo DNA methylation: A germ cell perspective[J]. Trends Genet., 2012, 28(1): 33-42.
4	HAJKOVA P, ANCELIN K, WALDMANN T, et al.. Chromatin dynamics during epigenetic reprogramming in the mouse germ line[J]. Nature, 2008, 452(7189): 877-881.
5	HAJKOVA P. Epigenetic reprogramming--taking a lesson from the embryo[J]. Curr. Opin. Cell Biol., 2010, 22(3): 342-350.
6	IYER L M, ZHANG D, DE SOUZA R F, et al.. Lineage-specific expansions of TET/JBP genes and a new class of DNA transposons shape fungal genomic and epigenetic landscapes[J]. Proc. Natl. Acad. Sci. USA, 2014, 111(5): 1676-1683.
7	ZHU F, ZHU Q, YE D, et al.. Sin3a-Tet1 interaction activates gene transcription and is required for embryonic stem cell pluripotency[J]. Nucl. Acids Res., 2018, 46(12): 6026-6040.
8	LI X, YUE X, PASTOR W A, et al.. Tet proteins influence the balance between neuroectodermal and mesodermal fate choice by inhibiting Wnt signaling[J/OL]. Proc. Natl. Acad. Sci. USA, 2016, 113(51): E8267-E8276 [2022-06-11]. .
9	KOIVUNEN P, LAUKKA T. The TET enzymes[J]. Cell Mol. Life Sci., 2018, 75(8): 1339-1348.
10	MAHAJAN V, FARQUHAR C, PONNAMPALAM A P. Could DNA hydroxymethylation be crucial in influencing steroid hormone signaling in endometrial biology and endometriosis?[J]. Mol. Reprod. Dev., 2020, 87(1): 7-16.
11	SARKAR D, LEUNG E Y, BAGULEY B C, et al.. Epigenetic regulation in human melanoma: past and future[J]. Epigenetics, 2015, 10(2): 103-121.
12	TERRADAS-TERRADAS M, ROBERTSON N A, CHANDRA T, et al.. Clonality in haematopoietic stem cell ageing[J/OL]. Mech. Ageing Dev., 2020, 189: 111279 [2021-12-05]. .
13	LORSBACH R B, MOORE J, MATHEW S, et al.. TET1, a member of a novel protein family, is fused to MLL in acute myeloid leukemia containing the t(10;11)(q22;q23)[J]. Leukemia, 2003, 17(3): 637-641.
14	ROSS S E, BOGDANOVIC O. TET enzymes, DNA demethylation and pluripotency[J]. Biochem. Soc. Trans., 2019, 47(3): 875-885.
15	HU L, LI Z, CHENG J, et al.. Crystal structure of TET2-DNA complex: insight into TET-mediated 5mC oxidation[J]. Cell, 2013, 155(7): 1545-1555.
16	MELAMED P, YOSEFZON Y, DAVID C, et al.. Tet enzymes, variants, and differential effects on function[J/OL]. Front. Cell Dev. Biol., 2018, 6: 22 [2021-12-05]. .
17	TAHILIANI M, KOH K P, SHEN Y, et al.. Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1[J]. Science, 2009, 324(5929): 930-935.
18	WU S C, ZHANG Y. Active DNA demethylation: many roads lead to Rome[J]. Nat. Rev. Mol. Cell Biol., 2010, 11(9): 607-620.
19	BOCHTLER M, KOLANO A, XU G L. DNA demethylation pathways: additional players and regulators[J]. Bioessays, 2017, 39(1): 1-13.
20	LIU Z J, MARTINEZ C S, DELFT P, et al.. Sequencing abasic sites in DNA at single-nucleotide resolution[J]. Nat. Chem., 2019, 11(7): 629-637.
21	GUO F, LI X, LIANG D, et al.. Active and passive demethylation of male and female pronuclear DNA in the mammalian zygote[J]. Cell Stem Cell, 2014, 15(4): 447-459.
22	HU L, LU J, CHENG J, et al.. Structural insight into substrate preference for TET-mediated oxidation[J]. Nature, 2015, 527(7576): 118-122.
23	LI W, LIU M. Distribution of 5-hydroxymethylcytosine in different human tissues[J/OL]. J. Nucl. Acids, 2011, 2011: 870726 [2021-12-06]. .
24	GLOBISCH D, MUNZEL M, MULLER M, et al.. Tissue distribution of 5-hydroxymethylcytosine and search for active demethylation intermediates[J/OL]. PLoS ONE, 2010, 5(12): e15367 [2021-12-06]. .
25	JIN S G, WU X, LI A X, et al.. Genomic mapping of 5-hydroxymethylcytosine in the human brain[J]. Nucl. Acids Res., 2011, 39(12): 5015-5024.
26	CAI J, CHEN L, ZHANG Z, et al.. Genome-wide mapping of 5-hydroxymethylcytosines in circulating cell-free DNA as a non-invasive approach for early detection of hepatocellular carcinoma[J]. Gut, 2019, 68(12): 2195-2205.
27	BENESOVA M, TREJBALOVA K, KUCEROVA D, et al.. Overexpression of TET dioxygenases in seminomas associates with low levels of DNA methylation and hydroxymethylation[J]. Mol. Carcinog., 2017, 56(8): 1837-1850.
28	ONO R, TAKI T, TAKETANI T, et al.. LCX, Leukemia-associated protein with a CXXC domain, is fused to MLL in acute myeloid leukemia with trilineage dysplasia having t(10;11)(q22;q23)[J]. Cancer Res., 2002, 62(14): 4075-4080.
29	HUANG H, JIANG X, LI Z, et al.. TET1 plays an essential oncogenic role in MLL-rearranged leukemia[J]. Proc. Natl. Acad Sci. USA, 2013, 110(29): 11994-11999.
30	SEETHY A, PETHUSAMY K, CHATTOPADHYAY I, et al.. TETology: epigenetic mastermind in action[J]. Appl. Bioche Biotechnol., 2021, 193(6): 1701-1726.
31	MORAN-CRUSIO K, REAVIE L, SHIH A, et al.. Tet2 loss leads to increased hematopoietic stem cell self-renewal and myeloid transformation[J]. Cancer Cell, 2011, 20(1): 11-24.
32	TEFFERI A, LIM K H, ABDEL-WAHAB O, et al.. Detection of mutant TET2 in myeloid malignancies other than myeloproliferative neoplasms: CMML, MDS, MDS/MPN and AML[J]. Leukemia, 2009, 23(7): 1343-1355.
33	WANG Y, XIAO M, CHEN X, et al.. WT1 recruits TET2 to regulate its target gene expression and suppress leukemia cell proliferation[J]. Mol. Cell, 2015, 57(4): 662-673.
34	PAN F, WINGO T S, ZHAO Z, et al.. Tet2 loss leads to hypermutagenicity in haematopoietic stem/progenitor cells[J/OL]. Nat. Commun., 2017, 8: 15102 [2021-12-05]. .
35	PULIKKOTTIL A J, BAMEZAI S, AMMER T, et al.. TET3 promotes AML growth and epigenetically regulates glucose metabolism and leukemic stem cell associated pathways[J]. Leukemia, 2022, 36(2): 416-425.
36	SZULWACH K E, LI X, LI Y, et al.. Integrating 5-hydroxymethylcytosine into the epigenomic landscape of human embryonic stem cells[J/OL]. PLoS Genet., 2011, 7(6): e1002154 [2021-12-15]. .
37	MACARTHUR I C, DAWLATY M M. TET Enzymes and 5-Hydroxymethylcytosine in Neural Progenitor Cell Biology and Neurodevelopment[J/OL]. Front. Cell Dev. Biol., 2021, 9: 645335 [2022-02-05]. .
38	LIAN H, LI W B, JIN W L. The emerging insights into catalytic or non-catalytic roles of TET proteins in tumors and neural development[J]. Oncotarget, 2016, 7(39): 64512-64525.
39	RUDENKO A, DAWLATY M M, SEO J, et al.. Tet1 is critical for neuronal activity-regulated gene expression and memory extinction[J]. Neuron, 2013, 79(6): 1109-1122.
40	DAWLATY M M, BREILING A, LE T, et al.. Combined deficiency of Tet1 and Tet2 causes epigenetic abnormalities but is compatible with postnatal development[J]. Dev. Cell, 2013, 24(3): 310-323.
41	VERMA N, PAN H, DORE L C, et al.. TET proteins safeguard bivalent promoters from de novo methylation in human embryonic stem cells[J]. Nat. Genet., 2018, 50(1): 83-95.
42	PALMER A J, SAVERY D, MASSA V, et al.. Genetic interaction of Pax3 mutation and canonical Wnt signaling modulates neural tube defects and neural crest abnormalities[J/OL]. Genesis, 2021, 59(11): e23445 [2022-02-04]. .
43	LU X L, WANG L, CHANG S Y, et al.. Sonic hedgehog signaling affected by promoter hypermethylation induces aberrant Gli2 expression in spina Bifida[J]. Mol. Neurobiol., 2016, 53(8): 5413-5424.
44	FENG J, PENA C J, PURUSHOTHAMAN I, et al.. Tet1 in nucleus accumbens opposes depression- and anxiety-like behaviors[J]. Neuropsychopharmacology, 2017, 42(8): 1657-1669.
45	COCHRAN J N, GEIER E G, BONHAM L W, et al.. Non-coding and loss-of-function coding variants in TET2 are associated with multiple neurodegenerative diseases[J]. Am. J. Hum. Genet., 2020, 106(5): 632-645.
46	BECK D B, PETRACOVICI A, HE C, et al.. Delineation of a human mendelian disorder of the DNA demethylation machinery: TET3 deficiency[J]. Am. J. Hum. Genet., 2020, 106(2): 234-45.
47	XU W, YANG H, LIU Y, et al.. Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of alpha-ketoglutarate-dependent dioxygenases[J]. Cancer Cell, 2011, 19(1): 17-30.
48	CARELLA A, TEJEDOR J R, GARCIA M G, et al.. Epigenetic downregulation of TET3 reduces genome-wide 5hmC levels and promotes glioblastoma tumorigenesis[J]. Int. J. Cancer, 2020, 146(2): 373-387.
49	BRAY J K, DAWLATY M M, VERMA A, et al.. Roles and regulations of TET enzymes in solid tumors[J]. Trends Cancer, 2021, 7(7): 635-646.
50	GARCíA M G, CARELLA A, URDINGUIO R G, et al.. Epigenetic dysregulation of TET2 in human glioblastoma[J]. Oncotarget, 2018, 9(40): 25922-25934.
51	RAWLUSZKO-WIECZOREK A A, SIERA A, JAGODZINSKI P P. TET proteins in cancer: current ‘state of the art’‍[J]. Crit. Rev. Oncol. Hematol., 2015, 96(3): 425-436.
52	RASMUSSEN K D, HELIN K. Role of TET enzymes in DNA methylation, development, and cancer[J]. Genes Dev., 2016, 30(7): 733-750.
53	SHEN G, SHEN H, ZHANG J, et al.. DNA methylation in Hepatoblastoma-a literature review[J/OL]. Ital. J. Pediatr., 2020, 46(1): 113 [2021-12-09]. .
54	ZHANG J, HAN X, GAO C, et al.. 5-Hydroxymethylome in circulating cell-free DNA as a potential biomarker for non-small-cell lung cancer[J]. Genom. Proteom. Bioinform., 2018, 16(3): 187-199.
55	TSAGARATOU A, LIO C J, YUE X, et al.. TET Methylcytosine Oxidases in T Cell and B cell development and function[J/OL]. Front. Immunol., 2017, 8: 220 [2021-12-15]. .
56	APPLEBAUM M A, BARR E K, KARPUS J, et al.. 5-Hydroxymethylcytosine profiles are prognostic of outcome in neuroblastoma and reveal transcriptional networks that correlate with tumor phenotype[J/OL]. JCO Precis. Oncol., 2019, 3: PO.18.00402 [2021-12-08]. .
57	HE Y F, LI B Z, LI Z, et al.. Tet-mediated formation of 5-carboxylcytosine and its excision by TDG in mammalian DNA[J]. Science, 2011, 333(6047): 1303-1307.
58	TIE J, COHEN J D, WANG Y, et al.. Circulating Tumor dna analyses as markers of recurrence risk and benefit of adjuvant therapy for stage Ⅲ colon cancer[J]. JAMA Oncol., 2019, 5(12): 1710-1717.
59	XU T, GAO H. Hydroxymethylation and tumors: can 5-hydroxymethylation be used as a marker for tumor diagnosis and treatment?[J/OL]. Hum. Genomics, 2020, 14(1): 15 [2022-01-07]. .

[1]	Yujie WANG, Pengyi YANG, Yang LI, Yiyang LI, Zhongqiang LI, Hongshu SUI, Zengshuo MAN. Research Progress on the Mechanisms of Mercury Toxicity and Novel Prevention and Control Strategies [J]. Current Biotechnology, 2025, 15(4): 655-660.
[2]	Fan LIU, Chen CHEN, Yuanzhi ZHU, Yanjun FU, Lin WANG, Ting ZHANG, Shan WANG. Obstructive Sleep Apnea and Cognitive Impairment: A Review of Epigenetic Advances [J]. Current Biotechnology, 2024, 14(5): 805-812.

Progress on Biological Functions and Mechanisms of TET Enzymes

TET酶的生物学功能及相关机制的研究进展

RichHTML

PDF

Knowledge

Abstract

Cite this article

share this article

Figures/Tables 3

References 59

Related Articles 2

Recommended Articles

Metrics

Comments